Not sure what you point is borrowed.... Tobira has developing therapies and is actually a real pharma company. Concordia has old off-patent drugs that they have jacked up the prices on. There will always be takeovers at high premiums for innovative drug companies but no one believes that anyone is rushing to buy Concordia's declining portfolio that looks like it will have
...more